
Biotechnology
Innovations in cancer immunotherapy: Bi-specific T cell engagers
Bi-specific T cell engagers are poised to become key immunotherapy treatments due to simpler production and new safety advances.
Read the reportRead the articleDownload the summarySee the infographicRead the publicationRead the recapWatch the video






















